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Approximately 1e2 per 1000 newborn babies have a cardiac defect that is potentially life-threatening
usually because either the systemic or the pulmonary blood ﬂow is dependent on a patent ductus arte-
riosus. A signiﬁcant proportion of newbornswith such cardiac defects are being discharged fromwell-baby
nurseries without a diagnosis and therefore risk circulatory collapse and death. This risk is greatest for
defects with duct-dependent systemic circulation, notably aortic arch obstruction, but is also signiﬁcant in
transposition of the great arteries, for example. The solution to this problem, apart from improving prenatal
detection rates, is to introduce effective neonatal screening including routine pulse oximetry.
 2013 The Author. Published by Elsevier Ltd. Open access under CC BY-NC-ND license.1. Introduction
Cardiac malformations are the most frequently occurring of all
congenital malformations with a prevalence at live birth of around
0.8%.1e3 Most of these defects are not directly life-threatening for the
newborn. However, 10e20% of all neonates with cardiac malforma-
tions, corresponding to w1e2 per 1000 newborns, have a cardiac
defect that if undetected may cause circulatory collapse and death
during the neonatal period.4e9 Abu-Harb et al.4 found that cardio-
vascular malformations accounted for 9% of all infant deaths and 43%
of all infantdeaths due to congenitalmalformations. In that study30%
of the cases were not diagnosed before death. Most of these cardiac
defects are life-threatening because they have a duct-dependent
systemic or pulmonary circulation. A smaller proportion are life-
threatening because they cause severe cardiac failure or arterial
desaturation that develop early for other reasons than ductal closure.
The purpose of this article is to review the diagnosis and man-
agement of cardiac malformations that are life-threatening to the
newborn with emphasis on how to avoid circulatory collapse and
death through early postnatal diagnosis when the lesion has not
been diagnosed prenatally.
Primary heart disease other than cardiac malformations may
also be life-threatening to the neonate, although more rarely, forLtd. Open access under CC BY-NC-ND example cardiac arrhythmias, cardiomyopathies, cardiac tumours
and myocarditis. These are beyond the scope of this review.
2. Cardiac malformations that are potentially life-
threatening to the newborn
The most widespread cardiac malformations with duct-
dependent systemic circulation are coarctation of the aorta
(CoA) and interrupted aortic arch (IAA), critical aortic valve ste-
nosis (AoS) and hypoplastic left heart syndrome (HLHS). In CoA,
the lower body is supplied by ﬂow through the ductus arteriosus.
In IAA type B, also the left subclavian artery and in type C the left
carotid are supplied by the duct. In HLHS and AoS the circulation
to both the upper and lower part of the body is dependent on ﬂow
from the right ventricle through the ductus arteriosus. Sometimes
obstruction to systemic ﬂow occurs at several levels simulta-
neously, for example CoA and aortic valve stenosis or a supra-
valvular mitral membrane, parachute mitral valve, subaortic
stenosis and CoA (Shone’s complex).
Duct-dependent pulmonary blood ﬂow occurs in pulmonary
atresia with intact ventricular septum (PA/IVS), critical pulmonary
valve stenosis (CPS), tetralogy of Fallot (ToF) with critical subvalvar
and/or valvar pulmonary stenosis, pulmonary atresia with ven-
tricular septal defect without collateral ﬂow to the lungs (PA/VSD),
tricuspid atresia (TA) with a restrictive VSD and in some forms of
severe Ebstein’s anomaly. In simple transposition of the great ar-
teries (TGA) the mixing of systemic and pulmonary venous blood is
dependent mainly on a patent foramen ovale but a patent ductus
arteriosus is often also necessary to optimize mixing. For thelicense.
M. Mellander / Seminars in Fetal & Neonatal Medicine 18 (2013) 302e310 303purpose of this review, TGA is considered among the defects with
duct-dependent pulmonary blood ﬂow.
Some cardiac defects can be life-threatening to the newborn
even if neither the systemic nor the pulmonary blood ﬂow is duct-
dependent. One such cardiac defect is total anomalous pulmonary
venous return (TAPVR) with obstruction to pulmonary venous ﬂow.
3. Missed diagnoses
A signiﬁcant proportion of newborns with life-threatening car-
diac defects are being discharged fromwell-baby nurseries without
a diagnosis.4e8,10e12 In a study based on 351 843 births in Sweden,
259 newborns had critical cardiac defects deﬁned as those
requiring surgical or catheter-based intervention before 2 months
of age. The most numerous defects were CoA (n ¼ 64), HLHS
(n ¼ 51) and TGA (n ¼ 64). Out of 129 with duct-dependent sys-
temic circulation, 38 (30%) were discharged home without suspi-
cion of heart disease.7 The corresponding proportion for those with
duct-dependent pulmonary circulation was lower at 4 of 106. More
than 40% of those discharged undiagnosed were in circulatory
shock at admission. The most common diagnosis among those
discharged was CoA. This was in concordance with other studies
showing that aortic arch obstruction is the most frequently missed
defect.5,12 It was also shown that the proportion of newborns with a
life-threatening cardiac malformation who were discharged undi-
agnosed increased in parallel with the increasing proportion of
mothers discharged early from maternity units. One explanation of
this observation is that early discharge allows less time for the baby
to develop detectable signs and symptoms of heart disease while
still in hospital.7 In a later study 44% of newborns with TGA left
hospital undiagnosedwhen pulse oximetry screeningwas not used,
presumably as a result of even earlier discharge.9 Thus it is clear
that one important area for improvement, apart from prenatal
detection rates, is the newborn screening routines.
4. Newborn screening for congenital heart defects
Early diagnosis of severe heart disease in the newborn is
improved if the examiner has a high index of suspicion and an
awareness of the important symptoms and physical ﬁndings.
4.1. Symptoms and signs
Increased respiratory rate and/or cyanosis are themost common
presenting symptoms. On physical examination a murmur,
increasedprecordial activity,weakorabsentbrachial and/or femoral
pulses and poor peripheral perfusion are signs that should raise the
suspicion of a cardiac defect. However, less than half of all newborns
with congenital cardiac malformations have a murmur and heart
murmurs do not occur more frequently in more severe heart de-
fects.11 Importantly, a newborn babywith a duct-dependent cardiac
defect may not have any symptoms at all as long as the duct is still
widely patent, and physical examination may be normal. This is
especially true for defects with duct-dependent systemic circula-
tion. In CoA and IAA, for example, femoral pulses may be normal
while the duct is patent because the right ventricle supplies the
descending aorta through the duct. Respiratory rate and peripheral
perfusion may also be normal initially. Oxygen saturations can be
normal also in the lower body because of a large left-to-right shunt
at the atrial level. When the duct begins to constrict, symptoms
develop gradually or rapidly depending on the rate of constriction.
Respiratory rate increases, peripheral perfusion decreases and pul-
ses become weaker or disappear. Diuresis decreases and there is
increasing metabolic acidosis and if undetected eventually circula-
tory collapse and death.In defects with duct-dependent pulmonary blood ﬂow, arterial
desaturation is more pronounced because of restriction to pulmo-
nary blood ﬂow and cyanosis is therefore more readily apparent.
4.2. Pulse oximetry screening
Pulse oximetry screening has been evaluated in a few large
studies.9,13e17 In a study in Sweden the criteria for a positive screen
result was a preductal and postductal oxygen saturation <95% or a
difference between the two measurements >3% on three repeated
measurements.9 The screening region (46 963 births) was
compared with the rest of the referral area for pediatric cardiac
surgery not using pulse oximetry screening (108 604 births). The
risk of leaving hospital with undiagnosed duct-dependent circu-
lation was 5/60 in the screening region compared with 28/100 in
the other referring regions and the mortality was signiﬁcantly
higher among those discharged undiagnosed.9 Importantly the
false-positive rate was higher with physical examination than with
pulse oximetry (1.90% vs 0.17%). Five cases were missed by com-
bined physical examination and pulse oximetry9 and all had aortic
arch obstruction (CoA or IAA). Furthermore, 8 out of 11 cases with
CoA or IAA fulﬁlled the criteria for a normal pulse oximetry
screening test.
Thus aortic arch obstruction is not only one of the most
frequent duct-dependent lesions (together with HLHS and TGA)
but also the one that is most frequently missed on routine neonatal
examination and unfortunately the defect most often missed by
pulse oximetry screening. In addition, CoA is one of the most
difﬁcult lesions to detect on antenatal ultrasound screening.18
Postnatally there is some promise in the so-called peripheral
perfusion index (PPI).19 PPI reﬂects the real-time changes in pe-
ripheral blood ﬂow. The ratio of the pulsatile to non-pulsatile
components of the infrared signal (PPI) corresponds to the rela-
tionship between pulsatile and non-pulsatile ﬂow at the site.19 It
remains to be determined in a prospective studywhether the use of
this index will increase the timely postnatal detection of CoA.
TGA is also a challenge; as with CoA it is difﬁcult to diagnose
prenatally18 unless the screening protocol includes outﬂow views
and the three vessel and tracheal view. An improvement in prenatal
detection rates has been reported from some areas.20 In maternity
wards not using pulse oximetry screening, a signiﬁcant proportion
will also be overlooked postnatally because the mixing at the atrial
and ductal levels in some cases is so good that there will be no
visible cyanosis during the ﬁrst few days. In the Swedish pulse
oximetry study 44% of the newborns with TGA (11/25) left the
hospital undiagnosed if pulse oximetry was not used versus 0% (0/
18) in the screening region.9 One of those 11 died undiagnosed and
three suffered preoperative cerebral hemorrhage or seizures. Even
with neonatal pulse oximetry screening newborns with TGA are at
risk if born in a hospital without specialized pediatric cardiac care.
Some of these infants may have profound hypoxia from birth
because of a severely restrictive foramen ovale and will need an
emergency Rashkind septostomy. A prenatal diagnosis would
eliminate this problem since delivery can then be planned in a
specialist centre. TGA was the ﬁrst cardiac defect for which it was
clearly shown that a prenatal diagnosis was associated with a
signiﬁcantly better survival21 and neurocognitive outcome.20
Pulse oximetry screening is now becoming standard care in
all maternity wards in Sweden and in other countries as well,
including the USA after it was endorsed by the Department of
Health and Human Services in September 2011.22,23 This initiative,
together with increasing antenatal detection rates of critical cardiac
malformations, should result in a decrease in the proportion of
undiagnosed newborns who are discharged from the maternity
wards.
Fig. 1. Coarctation of the aorta with a patent ductus arteriosus providing ﬂow to the
lower body.
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Any newborn baby with signs or symptoms suggestive of heart
disease (which are not obviously explained by another problem)
and/or positive pulse oximetry screening should have an echocar-
diographic examination as soon as possible. Such signs and
symptoms could be a murmur, increased respiratory rate, increased
precordial activity, weak or absent femoral and/or brachial pulses
and poor peripheral perfusion. If the only sign is a murmur it may
be acceptable to wait one day while the baby remains in the ma-
ternity ward, and, if the murmur is still there the day after, perform
echocardiography before discharge. A negative pulse oximetry
screening result does not completely rule out a life-threatening
cardiac defect. As mentioned above, especially newborns with
aortic arch obstruction may have normal saturations in both upper
and lower extremities.
Echocardiography is the mainstay in the diagnostic arsenal for
cardiacmalformations. It will give the exact anatomic and functional
diagnosis in most cases. Electrocardiography (ECG), although
sometimes typical for a certain cardiac defect, is usually not helpful
in the differential diagnosis. It can be completely normal also in life-
threatening duct-dependent lesions, showing only the normal
neonatal right heart dominance. The same is true for chest X-ray.
The main diagnostic contribution from chest X-ray is to rule out
concomitant pulmonary disease and to see whether pulmonary
vascular markings are increased or decreased. Sometimes there is a
typical cardiac silhouette in ToF, TGA or TAPVR, for example, but this
will not usually provide information additional to echocardiography.
Therefore, echocardiography should not be postponed in a newborn
with signs or symptoms suggestive of heart disease and/or low
oxygen saturation just because ECG and/or chest X-ray are normal.
Sometimes echocardiography cannot completely deﬁne the
diagnosis and provide all necessary details. In CoA, for example,
echocardiography may give the diagnosis but not describe the
entire aortic arch in enough detail for the surgeon to plan surgery,
or it may be uncertain whether the aortic narrowing found on
echocardiography is of sufﬁcient magnitude to make systemic cir-
culation to the lower part of the body duct-dependent. In such a
situation computed tomography (CT) can be helpful. Nevertheless a
question may remain about duct dependency and in borderline
cases it is usually necessary to discontinue prostaglandins and
follow the Doppler gradient across the narrowing while the duct
constricts before deciding about surgery. Anomalous pulmonary
veins are sometimes difﬁcult to map using echocardiography, and,
in complex cardiac defects involving the pulmonary veins, CT and/
or angiography may be required.
6. Management
If the cardiac defect is diagnosed before birth and is considered
to be duct-dependent, the baby should be delivered in a tertiary
centre with full pediatric cardiology/cardiac surgery service as well
as neonatal intensive care in order to avoid neonatal transport and
to optimize neonatal management. Cesarean section is seldom
indicated because of a fetal cardiac defect. One exception may be in
the case of TGA with a high risk of need for emergency Rashkind
septostomy immediately after birth based on prenatal examination
of the foramen ovale and ductus arteriosus.24 Another example is
total anomalous pulmonary venous return with obstruction to
pulmonary venous ﬂow. In this defect, emergency cardiac surgery
may be the only option since prostaglandins will not be of beneﬁt.
However, total anomalous pulmonary venous return is still rarely
diagnosed before birth.25
After postnatal diagnosis of a duct-dependent lesion the baby is
started on i.v. prostaglandin E1 infusion to maintain ductal patency.In case the duct has already started to constrict, a higher dose is used
to open it (50e100 ng kg1 min1) and then after an hour or so
(when echocardiography conﬁrms a widely patent duct) continued
with maintenance dose (usually 5e20 ng  kg1  min1). If the
presentation is with circulatory collapse because the diagnosis was
not suspected before ductal constriction and there is no other
obvious explanation for the deterioration, the baby should be star-
ted on prostaglandins simultaneously with resuscitation on the
suspicion that it could be a duct-dependent cardiac defect. After
stabilization, plans for continued management can be drawn. A
period of recovery is usually advisable before surgery, ensuring
restoration of cerebral, renal and liver function. In severe cases with
unstable hemodynamics despite opening up the duct (usually
because of myocardial dysfunction and/or atrioventricular valve
regurgitation), or if the duct does not respond, treatment with
extracorporeal membrane oxygenation may be necessary before
surgery.
Below follows a short review of the principles of management
for the most common of these cardiac defects.
7. Duct-dependent systemic circulation
7.1. Coarctation of the aorta (Fig. 1)
Once the diagnosis is established and the anatomy is clear,
surgery can be planned, usually within a few days or towards the
end of the ﬁrst week. Interventional catheterization for primary
treatment of neonatal coarctation is not performed in most centers
but catheter intervention with balloon or stent dilatation has an
important role in the management of recoarctations. The surgical
approach depends on the degree of aortic arch hypoplasia and if the
coarctation is isolated, if there is also a VSD, or if the CoA is part of a
Fig. 3. Critical aortic valve stenosis with a patent ductus arteriosus.
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are excellent and freedom from reintervention at medium term
follow-up after extended resection and end-to-end anastomosis
was 94% in one series.26 Nevertheless hypertension remains a
frequent complication on long-term follow-up after early repair.27
7.2. Interrupted aortic arch (Fig. 2)
This defect, which occurs much less frequently than CoA, is
almost invariably associated with VSD and is often a part of a more
complex cardiac malformation. The interruption can occur at
different sites; after all arch vessels (type A), before the left sub-
clavian artery (type B) or before the left carotid artery (type C)
resulting in different patterns of peripheral pulse weakness when
the duct constricts. The presentation and management is similar to
CoA and results depend on associated anomalies.
7.3. Critical aortic valve stenosis (Fig. 3)
For the purpose of this review AoS is deﬁned as a stenosis of the
aortic valve that is severe enough to render the whole or part of the
systemic circulation duct-dependent. Left ventricular function can
be preservedwith a high pressure gradient across the valve or there
can be different degrees of depression of left ventricular contrac-
tility. Sometimes the left ventricle is dilated with very poor con-
tractions and with almost no ﬂow across the valve. The diameter of
the aortic valve ring and the size of the left ventricle and mitral
valve determine management. There is a spectrum of severity
merging at one end into HLHS and it is sometimes difﬁcult to judge
whether a biventricular circulation is possible. Management can
vary from surgical or catheter-based valvotomy in the less severe
cases to so-called RosseKonno surgery if the valve ring is too smallFig. 2. Interrupted aortic arch type B (between the left carotid and subclavian arteries)
with a ventricular septal defect. The descending aorta is supplied via the ductus.but the left ventricle deemed capable of supporting systemic cir-
culation. A primary decision to go for a biventricular circulation can
turn out to be wrong and one may have to convert to a uni-
ventricular circulation through a Norwood procedure. Even in the
most favourable cases the subsequent course includes in many
cases the need for surgical or catheter-based reinterventions and
ﬁnally often valve replacement. In a recently published long-term
follow-up after neonatal surgical valvotomy the freedom from
aortic valve replacement was 57% at 20 years.28
7.4. Hypoplastic left heart syndrome (Fig. 4)
In classical HLHS (aortic and mitral atresia) the whole of the
systemic circulation passes through the duct and the ﬂow through
the aortic arch and ascending aorta is retrograde. If undetected,
circulatory collapse will occur with ductal constriction, but even
with a widely patent duct the baby may deteriorate preoperatively
when pulmonary vascular resistance decreases leading to increased
pulmonary ﬂow at the expense of systemic ﬂow. Therefore, in
HLHS, oxygen administration should be avoided in order not to
stimulate pulmonary vasodilatation and it will sometimes even be
necessary preoperatively to intubate and hypoventilate or admin-
ister inhaled CO2 or nitrogen to balance systemic and pulmonary
perfusion. The optimal timing of Norwood surgery depends on the
clinical situation but surgery is usually performed towards the end
of the ﬁrst week. An alternative to Norwood surgery as the ﬁrst
stage is a hybrid procedure including transcatheter stenting of the
duct and bilateral pulmonary artery banding.29,30 Whether results
are better or worse thanwith Norwood surgery is not yet known, in
part because this approach is often reserved for the more difﬁcult
cases.31
The epidemiology of HLHS is rapidly changing. Infants with this
cardiac defect had a 100% mortality until William Norwood
developed a surgical approach (Norwood surgery) in the 1980s
which was gradually adopted by many centers beginning during
Fig. 4. Hypoplastic left heart syndrome with mitral and aortic atresia and hypoplasia
of the ascending aorta. The whole of the systemic ﬂow is supplied by the right ventricle
through the ductus.
Fig. 5. Pulmonary atresia with intact ventricular septum. Pulmonary ﬂow is via a
patent ductus.
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(Norwood þ bidirectional Glenn procedure þ total cavopulmonary
anastomosis) has improved gradually and is in the range of 50e70%
today in most centres.32 In parallel with this development, prenatal
screening for cardiac defects was introduced in many countries and
HLHS was increasingly diagnosed prenatally, much more so than
for example TGA, ToF and CoAwhich are more difﬁcult to detect. In
countries where pregnancy termination is an option for fetal car-
diac malformation an increasing number of fetuses with HLHS are
terminated. The incidence at birth of this heart defect is therefore
decreasing in many countries.33
8. Duct-dependent pulmonary circulation
8.1. Pulmonary atresia with intact ventricular septum (Fig. 5)
In PA/IVS a left-to-right shunt across the duct provides the
pulmonary ﬂow and the baby is stabilized with prostaglandins.
Subsequent management depends on right ventricular size and
morphology, the tricuspid valve size and whether right ventricular-
dependent coronary circulation is present. If the latter is not the
case, the atresia is membranous and the right ventricle and
tricuspid valve are not too hypoplastic, it may be possible to open
up the atretic pulmonary valve surgically or by catheter interven-
tion with the aim of achieving a biventricular circulation as a ﬁnal
result. Continued infusion of prostaglandin or a surgical systemic to
pulmonary artery shunt may be necessary for a period to increase
pulmonary blood ﬂow. At the other end of the spectrum the right
ventricle is diminutive and thick-walled, the tricuspid valve isseverely hypoplastic and there is a muscular pulmonary atresia and
often right ventricle-dependent coronary circulation. The ﬁrst
procedure in such a case is usually a surgical systemic-to-
pulmonary artery shunt and the treatment pathway is a staged
univentricular palliation. In a complete national cohort in Sweden,
survival to 10 years was 68%34 and in a recent report from Australia
survival to 10 years was 80%.35 A biventricular outcome was ach-
ieved in 62%34 and 56%35 of survivors respectively.
8.2. Critical pulmonary valve stenosis
Only a few cases of pulmonary valve stenosis are so severe that
the newborn baby will die when the duct closes. The incidence is in
the same range as PA/IVS; 10 of 259 newborns with life-threatening
cardiac malformations had CPS and 12 had PA/IVS in one study.7
The malformation belongs to the same spectrum of disease as PA/
IVS and the management is similar.
8.3. Tetralogy of Fallot (Fig. 6) and pulmonary atresia with VSD
(Fig. 7)
If the subvalvar and/or valvar obstruction in ToF is severe
enough at birth, the pulmonary circulation will be duct-dependent
and initial management is either a surgical shunt followed by
complete repair later or neonatal complete repair.
In PA/VSD only those cases with central pulmonary arteries
supplied only or mainly by the duct will be life-threatening to the
newborn. Because of the VSD both ventricles are well developed
and a systemic-to-pulmonary artery shunt operation after birth is
usually the ﬁrst procedure, followed by VSD closure and re-
establishment of the connection between the right ventricle and
pulmonary arteries with a conduit at 1e2 years.
Fig. 6. Tetralogy of Fallot with subvalvar and valvar pulmonary stenosis and a ven-
tricular septal defect. The right ventricular outﬂow obstruction in this case is so severe
that pulmonary ﬂow is duct-dependent.
Fig. 7. Pulmonary atresia with ventricular septal defect. There is no other blood supply
to the lungs in this case than from the aorta through the patent ductus.
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of symptomatic ToF or PA/VSD was 93% and the 5-year freedom
from reoperation was 58%.36 In a recent report of neonates with
symptomatic ToF, survival was 92% and freedom from reoperation
at 5 years 70e80% depending on surgical approach (shunt or
repair).37
8.4. Tricuspid atresia (Fig. 8)
In tricuspid atresia there is usually a VSD through which blood
can reach the pulmonary circulation or the systemic circulation if
there is also transposition of the great arteries. If the VSD is too
small, pulmonary (or systemic) blood ﬂow will be duct-dependent.
Initial management depends on anatomy. A staged univentricular
palliation follows. Ten-year survival after surgery for univentricular
heart with left ventricular dominance has been reported to
approach 90% in a recent series.38
8.5. Ebstein anomaly (Fig. 9)
Ebstein anomaly is extremely variable in its severity. Only severe
forms are life-threatening in the neonatal period. The malformed
tricuspid valve can cause severe regurgitation and massive cardiac
enlargement in fetal life. This may cause lung hypoplasia which
may sometimes be so severe that neonatal survival is not possible.
Even if this is not the case the right ventricle may not be able to
eject blood to the pulmonary artery, the whole stroke volume re-
gurgitates back into the right atrium, and pulmonary blood ﬂow
will be duct-dependent. It is sometimes difﬁcult on echocardiog-
raphy to determine whether this type of ‘functional’ pulmonary
atresia is present or whether there is Ebstein anomaly plus
anatomical pulmonary valve atresia. The management then is
usually to wait for a few days with the baby on prostaglandins. InFig. 8. Tricuspid atresia with a small ventricular septal defect (VSD) and normally
related great arteries. Pulmonary blood ﬂow depends on a patent ductus arteriosus
because the VSD is so small.
Fig. 9. Ebstein anomaly, i.e. displacement of a dysplastic tricuspid valve into the right
ventricle resulting in an ‘atrialized’ portion of the right ventricle. Pulmonary blood
ﬂow depends on a patent ductus because of poor or no forward ﬂow through the
pulmonary valve secondary to a large tricuspid regurgitation.
Fig. 10. Transposition of the great arteries. There is possibility for mixing at the atrial
and ductal levels.
Fig. 11. Total anomalous pulmonary venous returnwith a pulmonary venous conﬂuence
behind the left atriumandavertical veindescending through thediaphragm.Dorsal view.
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ﬂow may increase across the pulmonary valve if the ‘atresia’ is
functional. Nevertheless a surgical systemic-to-pulmonary artery
shunt is often necessary initially although it was recently reported
that the 15-year survival after complete repair in critically ill
neonates was 74%.39
8.6. Transposition of the great arteries (Fig. 10)
When TGA has been diagnosed and the baby is on prostaglan-
dins the level of the arterial oxygen saturation determines whether
a Rashkind septostomy is necessary. The arterial switch operation is
usually performed within 1e2 weeks of birth and a septostomy is
not necessary if arterial saturations are acceptable and stable
(>70%) on treatment with prostaglandin. It has been reported that
infants undergoing a Rashkind procedure for TGA have an increased
risk of preoperative stroke40 but this association has subsequently
been questioned.41 Long-term survival (25 years) after the arterial
switch procedure exceeded 95% in a recent report.42
8.7. Total anomalous pulmonary venous return with obstruction to
pulmonary ﬂow (Fig. 11)
Total anomalous pulmonary venous return is life-threatening to
the newborn only if there is obstruction to pulmonary venous re-
turn. This occurs most frequently in the infradiaphragmatic type,
when obstruction is almost invariably present. The pulmonary
venous blood then passes through a vertical vein down through
the diaphragm and usually enters the portal vein system. The
obstruction is at this entry site. If severe, the baby will have pro-
nounced desaturation from birth with respiratory distress because
of pulmonary edema. This is the only cardiac defect with this
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pulmonary edema similar in appearance to meconium aspiration.
Therefore a high index of suspicion is required for early diagnosis.
Management after diagnosis is emergency open heart surgery.
Prostaglandins are of no help in this situation. The 3-year survival
after surgery was around 80% in a recent report.43
9. Conclusions
The survival after surgery for congenital heart malformations
has improved substantially and the long-term prognosis is also
good for most of the cardiac defects that are life-threatening to the
neonate, such as aortic arch obstruction and TGA. This makes it
even more important to ensure that newborn babies with such
defects are diagnosed in time before circulatory collapse occurs.
The way to achieve this is a combined approach with improvement
of both prenatal detection rates and postnatal screening routines.
The rate of missed diagnoses of life-threatening cardiac defects in
the neonate is an important indicator of quality of care that should
be monitored continuously.
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